All weekly reports
The 10 Most Shorted ASX Stocks · Week 17, 2020
Weekly Short Selling Report
20 Apr 2020 — 24 Apr 2020
By Shorted AI Research · Published · Sourced from official ASIC short position reports (T+4 delay). Methodology · Not financial advice.
Stocks Shorted
552
Most Shorted
14.83%
GXY
Trading Days
5
Daily Snapshots
Top Shorted Stocks This Week
#
Stock
Short %
1
GXY
Galaxy Resources
14.83%
2
MYR
Myer Holdings · Consumer Discretionary Distribution & Retail
14.07%
3
SDA
Speedcast Int
13.19%
4
NWSLV
News Corporation.. · Media & Entertainment
12.66%
5
ORE
Orezone Gold · Materials
12.33%
6
KLA
Kirkland Lake Gold Cdi1:1forexempt Xtse
11.46%
7
JBH
Jb Hi-Fi · Consumer Discretionary Distribution & Retail
10.83%
8
ING
Inghams Group · Food, Beverage & Tobacco
10.03%
9
PLS
Pls Group · Materials
9.66%
10
CUV
Clinuvel Pharmaceuticals · Pharmaceuticals, Biotechnology & Life Sciences
9.54%
Financial Snapshot
Key financial metrics from recent company reports for the most shorted stocks.
MYRMyer HoldingsAppendix 4E - Annual Financial Report (FY26) (2026-09-23)
Dividend: 1.5c(52 weeks ended 25 July 2026)
Ebitda: $413.5M(52 weeks ended 25 July 2026)
Eps: -16.0c(52 weeks ended 25 July 2026)
Net Profit: $-276.5M(52 weeks ended 25 July 2026)
OREOrezone GoldQ1 Financial Statements - 31 March 2026 (2026-05-14)
Dividend: 12.0c(FY2024)
Ebitda: $320M(FY2024)
Eps: 7.0c(Q1 FY2026)
Eps: 35.5c(FY2024)
JBHJb Hi-FiAnnual Report 2026 - with Chair's & CEO's Report (2026-09-11)
Dividend: 337.0c(full year ended 30 June 2026)
Eps: 448.1c(full year ended 30 June 2026)
Net Profit: $489.9M(full year ended 30 June 2026)
Revenue: $11,060M(full year ended 30 June 2026)
INGInghams Group2026 Annual Report (2026-10-09)
Dividend: 10.1c(full year ended 30 June 2026)
Ebitda: $186.4M(full year ended 30 June 2026)
Net Profit: $34.6M(full year ended 30 June 2026)
PLSPls GroupFY26 Full Year Results (2026-08-24)
Dividend: 5.0c(full year ended 30 June 2026)
Ebitda: $1,137M(full year ended 30 June 2026)
Net Profit: $526M(full year ended 30 June 2026)
Revenue: $1,934M(full year ended 30 June 2026)
CUVClinuvel PharmaceuticalsAppendix 4E and Annual Report to Shareholders 2026 (2026-08-27)
Dividend: 2.4 A fully franked final dividend of $0.05 per ordinary sha(full year ended 30 June 2026)
Net Profit: $33.917M(full year ended 30 June 2026)
Revenue: $94.024M(full year ended 30 June 2026)
Track the live rankings on the most shorted ASX stocks page, watch short squeeze candidates, or see market-wide totals in the ASX short selling statistics.
Data sourced from ASIC short position reports (T+4 delayed). This report is for informational purposes only and does not constitute financial advice. Short selling data may not reflect real-time market conditions.